Brian Roberts
Analyst · Oppenheimer. Please go ahead.
Yeah, no, great question. I mean, as we've looked at the last couple of years to try to account for timing, you're right. We've been basically kind of converting half or slightly over half of our adjusted net income into free cash flow. I can sum it up in one word. It's inventory, right? And ultimately, that's the main -- big piece of it for us and a lot of focus. Obviously, over the last couple of years, there was a different prioritization where we needed to make sure the supply chain had enough redundancy in it or enough quantity in it, if you will, to be able to make sure we could meet customers demands. That was really important to the company. Now, in a more normalized environment, we're working hard to start taking down those inventory balances. That said, it's going to take a little bit of time, and that's why we've talked about higher cost of inventory that will impact adjusted operating margins in the first half of the year as well as we just work through kind of that overall normalization. Certainly receivable management, company does a good job there, but we can do better. And one of the reasons for, as we look at the end of this year, end of 2023 and beginning of 2024, you'll look at the balance sheet and note we really -- we didn't try to manage payables, right? So we let that kind of naturally flow as it should, which is why we got the result for 2023 and where we think we get the improvement for 2024. And then to your point, on the longer term, again, I'll come back to inventory. I mean, that's going to be a key piece for us.